Supriya Lifesciences IPO opens today. GMP, other details in 10 points

Supriya Lifescience IPO Membership Status

At 10:28 am on the first day of subscription, the public issue has been subscribed 0.47 times while the retail portion of the issue has been subscribed 2.43 times.

Here we list down the important Supriya Lifesciences IPO details in 10 points:

1]Supriya Lifesciences IPO GMP: As per market observers, Supriya Lifesciences IPO Gray Market Premium (GMP) is today 275 means gray market is expecting share listing of Supriya Lifescience 549 ( 274 + 275).

2]Supriya Lifescience IPO Subscribe or not: On Review of Supriya Lifesciences IPO; Abhay Doshi, Founder, UnlistedArena.com said, “On the operational front, the top and bottom line are showing growth as revenue grew by over 22.78%, EBITDA by over 62% and PAT by over 68% from FY20 to FY21 If we calculate the Annual Earnings P/E of 6MFY22 around 16.70x (Post Issue) which seems reasonable. Due to the issue of growth, attractive pricing and small size, we can see very strong interest from the participants . “

Ankur Saraswat, Research Analyst, Trustline Securities said, “The company is one of the leading API manufacturers and largest exporters of HCL and Salbutamol Sulphate in India. It has a backward integrated business and diversified product portfolio of 38 APIs with a long list of 1296 clients. The company has a global presence in 86 countries. It has advanced manufacturing and R&D capabilities and strong financial performance. Hence, sentiments are strong on the IPO based on this niche API products.”

3]Supriya Lifescience IPO Price Band: API manufacturer company has fixed the price band of its offer 265 to 274 per equity share.

4]Size of Supriya Lifesciences IPO: API maker company aims to mobilize 700 crore from its public offer ( 200 crore more from the fresh issue 500 crores through Offer for Sale or OFS).

5]Supriya Lifescience IPO Lot Size: A bidder will be able to apply for IPO in lots and one lot will consist of 54 shares of the company.

6]Supriya Lifescience IPO Application Range: A bidder can apply for a minimum of one lot and a maximum of 13 lots.

7]Supriya Lifescience IPO Investment Limit: Since a bidder can apply for a minimum of one lot and a maximum of 13 lots, the minimum amount required to apply for an IPO is 14,796 ( 174 x 54) while the maximum investment allowed in IPO is 1,92,348 [( ₹274 x 54) x 13],

8]Supriya Lifesciences IPO Allotment Date: The tentative date for allotment of shares is 23 December 2021. Refunds are expected to start from December 24 and credit of shares in the demat account of the allottees is expected on December 27, 2021.

9]Supriya Lifesciences IPO Listing: The shares of the company will be listed on both NSE and BSE.

10]Supriya Lifesciences IPO Listing Date: The tentative date for the company’s share listing is 28 December 2021.

Disclaimer: The views and recommendations given above are those of individual analysts or broking companies and not of Mint.